The global statin market was valued at USD 16.85 billion in 2024 and is expected to reach USD 24.34 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 4.70%, primarily driven by the rising prevalence of cardiovascular